Advisor OS LLC Sells 528 Shares of Chemed Co. (NYSE:CHE)

Advisor OS LLC decreased its holdings in Chemed Co. (NYSE:CHE) by 49.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 542 shares of the company’s stock after selling 528 shares during the period. Advisor OS LLC’s holdings in Chemed were worth $287,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of CHE. State Street Corp grew its position in shares of Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock valued at $279,063,000 after buying an additional 3,564 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Chemed by 4.9% in the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock worth $201,820,000 after acquiring an additional 15,791 shares during the period. Impax Asset Management Group plc boosted its holdings in Chemed by 4.7% in the third quarter. Impax Asset Management Group plc now owns 332,757 shares of the company’s stock valued at $199,977,000 after acquiring an additional 14,814 shares during the last quarter. Boston Trust Walden Corp increased its position in Chemed by 10.0% during the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock valued at $128,303,000 after purchasing an additional 22,105 shares during the period. Finally, FMR LLC raised its holdings in Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after purchasing an additional 45,917 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, VP Brian C. Judkins acquired 145 shares of the business’s stock in a transaction dated Monday, December 30th. The shares were bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Performance

Shares of CHE opened at $586.11 on Friday. The firm has a market cap of $8.82 billion, a PE ratio of 29.62, a price-to-earnings-growth ratio of 2.15 and a beta of 0.48. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62. The business’s 50 day moving average price is $543.86 and its two-hundred day moving average price is $563.11.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date is Monday, February 24th. Chemed’s dividend payout ratio is presently 10.11%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CHE. StockNews.com lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday. Royal Bank of Canada decreased their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.